Editorial Information

Trinseo Targets Medical Sector with Biocompatible Glass-Filled Polycarbonate

CALIBRE™ 5000 Series supports growth in minimally-invasive surgeries and industry cost reduction

BERWYN, Pa. - Wednesday, October 31, 2018

Trinseo  (NYSE: TSE) a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, is targeting the medical devices market with its biocompatible glass-filled polycarbonate resins. Trinseo’s CALIBRE 5000 series is an ideal material for metal substitution not only because of its strength and stiffness, but its added advantages of aesthetics, ergonomic improvements, and potential cost savings.

“As minimally-invasive surgeries increase and cost pressures continue to mount, Trinseo’s glass-filled polycarbonate is ideal for a variety of surgical tools and surgery access instruments,” said Arthas Yang, global marketing manager in Trinseo’s Performance Plastics business. “The material can be incorporated into a variety of applications, according to design and regulatory requirements, and can help manufacturers with their goals of lowering cost and increasing speed-to-market.”

Glass-filled materials have been used in numerous application areas for years. What differentiates Trinseo’s CALIBRE™ 5000 series is the fact that it has undergone extensive biocompatibility testing according to ISO 10993 standards to provide medical device manufacturers with added assurance of compliancy and patient safety.  

The CALIBRE™ 5000 series offers the following:

  • Custom glass content of up to 30 percent
  • Full battery of ISO 10993 biocompatibility testing
  • UL flammability ratings
  • Sterilizable  by EtO, gamma, and e-beam radiation

From an aesthetic perspective the material can be colored for branding and parts-identification purposes. Due to its processability and the design flexibility it allows, parts can be consolidated for cost savings and simplified assembly, reducing the number of seams and crevasses where bacteria can grow.  

Trinseo has supported the medical devices market for three decades.  The company offers a variety of plastics under the brands CALIBRE™ and CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, MAGNUM™ ABS  Resins, and STYRON™ Polystyrene Resins.  Thermoplastic elastomers offered by Trinseo for soft-touch medical applications are MEGOL™ MED TPS-SEBS Compounds and RAPLAN™ MED TPS-SBS Compounds.

About Trinseo

Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.8 billion in net sales with 2,700 employees globally in 2019. For more information, please visit: www.trinseo.com.

Note on Forward-Looking Statements

This press release may contain “forward-looking statements” including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “estimate,” “will,” “may,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Editorial Information

Get Exclusive Trinseo Content

Be the first to hear about new product information, company news, and more Trinseo updates conveniently via email!